Apollon Wealth Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
VCM
VPM
Apollon Wealth Management's DXCM Position: Q1 2026 in Review
Apollon Wealth Management increased its DexCom (DXCM) stake by 31% in Q1 2026, buying an estimated $355K and bringing the position to 21,420 shares worth $1.35M. The position accounts for 0.02% of the portfolio, ranked #490.
Apollon Wealth Management first reported a position in DXCM in Q2 2020 and has held it in 19 quarters since. The position peaked at $3.07M in Q1 2022. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Apollon Wealth Management held 21,420 shares of DexCom worth $1.35M as of Q1 2026.
- Apollon Wealth Management bought 5,099 DexCom shares in Q1 2026, an estimated $355K.
- DexCom made up 0.02% of Apollon Wealth Management's portfolio in Q1 2026, its #490 holding.
- Apollon Wealth Management first reported a position in DexCom in Q2 2020 and has held it in 19 quarters since.
- Apollon Wealth Management's DexCom position peaked at $3.07M in Q1 2022.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Apollon Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.